Sandra Horning

Sandra Horning is currently a Scientific Advisory Board Member at Foresight Diagnostics. Prior to this, they were with Moderna, EQRx, and Genentech/Roche. Sandra spent September 2009 to December 2019 at Genentech/Roche as Executive Vice President, Chief Medical Officer, Global Head of Product Development. Sandra Horning has also been with Stanford University School of Medicine in the past.

Sandra Horning has a post-graduate fellowship in oncology and cancer biology from Stanford University. Sandra also has a degree from the University of Iowa School of Medicine.